SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-098509
Filing Date
2024-04-17
Accepted
2024-04-17 06:25:33
Documents
22
Period of Report
2024-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816959d8k.htm   iXBRL 8-K 36615
2 EX-1.1 d816959dex11.htm EX-1.1 223441
3 EX-4.1 d816959dex41.htm EX-4.1 68432
4 EX-5.1 d816959dex51.htm EX-5.1 8542
5 EX-99.1 d816959dex991.htm EX-99.1 9687
6 EX-99.2 d816959dex992.htm EX-99.2 10353
10 GRAPHIC g816959dsp12.jpg GRAPHIC 14298
11 GRAPHIC g816959dsp17.jpg GRAPHIC 7920
12 GRAPHIC g816959dsp17a.jpg GRAPHIC 8103
13 GRAPHIC g816959g0417112720660.jpg GRAPHIC 4005
  Complete submission text file 0001193125-24-098509.txt   614653

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20240416.xsd EX-101.SCH 2833
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20240416_lab.xml EX-101.LAB 17979
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20240416_pre.xml EX-101.PRE 11247
25 EXTRACTED XBRL INSTANCE DOCUMENT d816959d8k_htm.xml XML 3637
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 24849333
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)